Purchase Order 75H71220P00170
- Not listed
- This is a $286,617.93 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for cost per test and supplies. The contract has a period of performance through July 31, 2023 and does not have a set-aside designation. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contracts and task orders to...
- This is a Delivery Order (DO) awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC. The DO is for COVID-19 testing panels and kits, and is issued under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The total ceiling value of this order is $68,984. Biofire Diagnostics LLC is a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. This order does...
- This firm fixed-price purchase order was awarded by the Indian Health Service, a civilian agency, to Biofire Diagnostics LLC, a for-profit foreign-owned company, to provide a molecular biology analyzer. The $20,752.50 contract has an ultimate completion date of October 31, 2021. It was awarded on September 10, 2020 and does not have a set-aside designation. The contract was issued against Biofire Diagnostics' General Services Administration Federal Supply Schedule contract for in-vitro...
- This federal contract award was made by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $92,180.60, is for the purchase of Biofire diagnostic products and services, including molecular diagnostic testing services, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. The...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit organization. The $149,038.88 contract is for a lab lease agreement and supplies, with a completion date of October 31, 2018. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contracts to provide a variety of related goods and services,...
- This is a firm-fixed-price purchase order awarded by the Indian Health Service, a civilian federal agency, to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company headquartered in Salt Lake City, Utah. The contract, valued at $267,240.00, is for the contractor to provide support services, service, parts, maintenance, phone support, on-site services, and software updates as required. The contract has a period of performance through September 25, 2028 and does not have a...
- This federal contract award was made by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $218,091.46 Firm Fixed Price purchase order is for CCHCF-FY2019 CH-LAB PRIORITY A CPT (BIOFIRE- IHS5419217) services to be delivered by December 31, 2019. The contract does not have a set-aside designation. Biofire Diagnostics LLC holds several indefinite...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in infectious disease testing, is for the purchase of BioFire FilmArray-Molecular equipment with a torch base and four years of warranty coverage. The $306,900.00 firm fixed-price purchase order was issued by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services. No set-aside designation was used. The award stems from a solicitation for BioFire...
- This is a sole source contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for cost per test and supplies. The contract has a ceiling value of $98,811.48 and was awarded on December 29, 2020 as a firm fixed price purchase order. The contract is for the lease of one FLM2-SRV-0001 instrument and associated supplies for the laboratory department at the Chinle...
- This is a $17,254.06 firm fixed price purchase order awarded to Biofire Diagnostics LLC, a for-profit foreign-owned biotech company, by the Bureau of Administration, a civilian federal agency. The contract is for the provision of medical supplies with no set-aside designation. Biofire Diagnostics LLC specializes in syndromic infectious disease testing and has an existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. This award...
This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC for the provision of a BIOFIRE ANALYZER, KITS AND PANELS, and UNO SERVICE UNIT to support COVID-19 response efforts. The award, valued at $57,100.00, has an ultimate completion date of October 31, 2021. Biofire Diagnostics LLC is a foreign-owned, for-profit organization that specializes in syndromic infectious disease testing. The company has previously received numerous federal contract and grant awards, and holds various indefinite delivery contracts and blanket purchase agreements with government agencies such as the Department of Veterans Affairs and the Indian Health Service to provide infectious disease testing products and services on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($24k) | 11/21/24 | |
| P00001 | Supplemental Agreement for work within scope | $19.6k | 12/4/20 | |
| Not listed | Not listed | $61.3k | 9/21/20 |